Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|March 25, 2011
Comparative outcomes of laparoscopic adjustable gastric banding in adolescents and adultsJeffrey L Zitsman, Mary F Digiorgi, Joshua R Marr, et al.
Journal of Neuroimmunology|August 6, 2002
Chemokine receptor CXCR2 regulates the functional properties of AMPA-type glutamate receptor GluR1 in HEK cellsP Lax, C Limatola, S Fucile, et al.
Gene Therapy|October 16, 2004
An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic modelM Hashimoto, E Rockenstein, M Mante, et al.
British Journal of Biomedical Science|February 25, 2021
Faecal immunochemical testing (FIT): sources of result variation based on three years of routine testing of symptomatic patients in English primary careT James, B D Nicholson, R Marr, et al.
Experimental Hematology|July 24, 2002
Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complexMeenakshi Noll, Kevin P Battaile, Raynard Bateman, et al.
The American Journal of Cardiology|June 15, 1989
Echocardiography by telephone--evaluation of pediatric heart disease at a distanceJ P Finley, D G Human, M A Nanton, et al.
Virology|September 1, 1993
Complete nucleotide sequence of HTLV-II isolate NRA: comparison of envelope sequence variation of HTLV-II isolates from U.S. blood donors and U.S. and Italian i.v. drug usersH Lee, K B Idler, P Swanson, et al.
Gynecologic Oncology|February 17, 2007
In vivo light scattering measurements for detection of precancerous conditions of the cervixJudith R Mourant, Thérese J Bocklage, Tamara M Powers, et al.
Experimental Hematology & Oncology|March 4, 2024
The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via inhibition of Wnt/β-catenin signalingAlexander R Marr, Madeline Halpin, Dominique L Corbin, et al.
Blood Cancer Discovery|November 5, 2025
PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor-Resistant Chronic Lymphocytic LeukemiaBritten K Gordon, Elizabeth M Muhowski, Jyotsana Singh, et al.
Pageof 4